A Study of RO7123520 to Evaluate the Safety and Efficacy in Participants With Moderately To Severely Active Rheumatoid Arthritis (RA) Who Are Inadequately Responding to Anti-Tumor Necrosis Factor (TNF)-Alpha Therapy
Clinical trial NCT03001219 · TERMINATED
Trial details
- NCT number
- NCT03001219
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-22
- Primary completion
- 2018-11-06
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.